Home  »  DPEE Test Series 2024 » Daily Quiz for DPEE: 07th January 2024

Daily Quiz for DPEE: 07 January 2024

To view Solutions, follow these instructions:

  1. To Start quiz click on – ‘Start Quiz
  2. Solve all Questions.
  3. Click on  ‘Quiz Summary’
  4. Click on ‘Finish Quiz
  5.  Click on ‘Finish Quiz ’ button to see the all Explanations.
98
Created by 05fe696f3a90485f423c585006cddec739726cdca3e2b834e4fe849c56c710f8?s=32&d=mm&r=g | Noteskarts, D.Pharma Notes PDF, D.Pharma 1st year Notes, Pharmacy Notes Noteskarts Daily Quiz for DPEE: 07 January 2024Noteskarts

Daily Quiz for DPEE: 07 January 2024

1 / 25

1. Can a repacking license be granted for the repacking of drugs for retail sale?

2 / 25

2. The subscription part of the prescription contains the:

3 / 25

3. Which authority is responsible for the approval of a new drug?

4 / 25

4. Pharmacy Council of India (PCI) is reconstituted:

5 / 25

5. Right statement for Drug_Food Interaction

6 / 25

6. What is a loan license?

7 / 25

7. Which of the following drugs is both a muscarinic and nicotinic blocker?

8 / 25

8. If the strength of the dilute solution is 1 in 4000, what is its percentage?

9 / 25

9.

Normal cholesterol range

10 / 25

10. The spinal cord is part of the:

11 / 25

11. What is a new drug?

12 / 25

12. Which of the following direct-acting cholinomimetics is mainly muscarinic in action?

13 / 25

13. The sympathetic nervous system is responsible for:

14 / 25

14. Can a repacking license be granted to a person who does not hold a manufacturing license?

15 / 25

15. Standard for mechanical contraceptive comes under Schedule ………………as per D & C Act

16 / 25

16. The group of nicotinic receptor-blocking drugs consists of:

17 / 25

17. M3 receptor subtype is located:

18 / 25

18. The hypothalamus is responsible for:

19 / 25

19.

Which does the term pharmacokinetics not include? (what the body does to the drug or how the drug gets in, around and out of the body)

20 / 25

20. Purpose of Phase-3 trial is

21 / 25

21. Indicate a muscarinic receptor-blocking drug:

22 / 25

22. In Phase-2 trial following number of patient should be studied

23 / 25

23. If drug is so colored, coated or polished that damage its therapeutic value or it is made to appear of better or greater therapeutic value than it really is known as

24 / 25

24. The pituitary gland is often referred to as the:

25 / 25

25. The thalamus is responsible for:

Your score is

The average score is 38%

0%

Exit

Noteskarts Test Series